Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_assertion description "[The PI3K/mammalian Target of Rapamycin (mTOR) pathway is often aberrantly activated in rhabdomyosarcoma (RMS) and represents a promising therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_assertion evidence source_evidence_literature NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_assertion SIO_000772 24133218 NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_assertion wasDerivedFrom befree-20140225 NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_assertion wasGeneratedBy ECO_0000203 NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP567051.RA9n59e2j-dbqAC_uZmWRukngrRbGEg0O4fNHVCnlAZMM130_provenance.